Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

SELL
$8.81 - $16.96 $159,187 - $306,450
-18,069 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$8.5 - $12.85 $148,163 - $223,988
-17,431 Reduced 49.1%
18,069 $160,000
Q3 2020

Nov 13, 2020

BUY
$9.57 - $27.05 $202,683 - $572,891
21,179 Added 147.89%
35,500 $412,000
Q2 2020

Aug 13, 2020

BUY
$7.14 - $31.69 $102,251 - $453,832
14,321 New
14,321 $384,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $546M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.